证券代码：600684 证券简称：珠江股份 编号：2025-039 广州珠江发展集团股份有限公司 第十一届董事会 2025 年第七次会议决议 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 广州珠江发展集团股份有限公司（以下简称"公司"）第十一届董事会 2025 年第七次会议于 2025 年 7 月 11 日以办公软件或电子邮件方式发出会议通 知及材料汇编，会议于 2025 年 7 月 16 日以通讯方式召开。本次会议应出席董 事 8 人，实际出席董事 8 人，由公司董事长李超佐先生召集并主持。会议的召 集、召开和表决程序符合有关法律、行政法规、部门规章、规范性文件和《公 司章程》的规定，并形成了如下决议： 本议案已经公司第十一届董事会薪酬与考核委员会 2025 年第二次会议审议 通过。 二、审议通过《关于聘任审计部负责人的议案》 表决情况：同意 8 票，反对 0 票，弃权 0 票。 鉴于梁景辉因工作调整不再担任公司审计部负责人，根据《内部审计工作 制度》等相关规定，同意聘任丘咏川为公司审计部负责人。丘咏川简历如下： 丘 ...

[Current Period Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company anticipates a turnaround to profitability in the first half of 2025, with net profit attributable to shareholders projected between **RMB 15.5 million and RMB 22.5 million**, and non-recurring net profit between **RMB 7 million and RMB 10.5 million**, based on unaudited preliminary estimates Current Period Performance Forecast | Indicator | Estimated Amount (RMB) | | :--- | :--- | | Performance Forecast Period | January 1, 2025 to June 30, 2025 | | Net Profit Attributable to Shareholders | RMB 15.5 million to RMB 22.5 million | | Net Profit Attributable to Shareholders Excluding Non-Recurring Items | RMB 7 million to RMB 10.5 million | - The company explicitly states that this performance forecast is based on preliminary calculations and has not been audited by an accounting firm[2](index=2&type=chunk) [Prior Period Performance Review](index=1&type=section&id=Item%202.%20Prior%20Period%20Operating%20Performance%20and%20Financial%20Status) In the first half of 2024, the company reported a net loss attributable to shareholders of **RMB 6.2359 million**, while net profit excluding non-recurring items was **RMB 22.2589 million**, indicating core business profitability 2024 H1 Actual Performance | Indicator | 2024 H1 Actual Amount (RMB) | | :--- | :--- | | Total Profit | RMB 2.7370 million | | Net Profit Attributable to Shareholders | -RMB 6.2359 million | | Net Profit Attributable to Shareholders Excluding Non-Recurring Items | RMB 22.2589 million | | Earnings Per Share | -RMB 0.01 | [Analysis of Performance Change](index=1&type=section&id=Item%203.%20Primary%20Reasons%20for%20Current%20Period%20Pre-Profit) The turnaround to profitability is primarily driven by changes in non-recurring gains and losses, specifically the fair value increase of equity investments due to the A-share market recovery in H1 2025, contrasting with prior period losses from market decline, while core business profitability (non-recurring net profit) has declined year-over-year - The primary reason for the turnaround to profitability is the change in fair value of the company's equity investments, with gains from A-share market recovery in H1 2025 contrasting with losses from market decline in the prior period[5](index=5&type=chunk) Performance Comparison | Indicator | 2025 H1 (Estimated) | 2024 H1 (Actual) | Key Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Parent | RMB 15.5-22.5 million | -RMB 6.2359 million | **Turnaround to Profit** (Impacted by non-recurring items) | | Net Profit Attributable to Parent Excluding Non-Recurring Items | RMB 7-10.5 million | RMB 22.2589 million | **Year-over-Year Decline** (Core business profitability weakened) | [Risk Warning](index=2&type=section&id=Item%204.%20Risk%20Warning) The company advises investors that the disclosed performance data are preliminary and unaudited, subject to potential differences from the final financial figures in the official 2025 semi-annual report, urging caution regarding investment risks - The announcement emphasizes that the forecast data are preliminary, and the final accurate financial figures will be based on the company's officially disclosed 2025 semi-annual report[6](index=6&type=chunk)

Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

广州珠江发展集团股份有限公司 关于聘任副总经理的公告 证券代码：600684 证券简称：珠江股份 编号：2025-037 赵坤先生简历如下： 赵坤，男，1984 年 6 月生，汉族，中共党员，研究生学历，硕士学位，体 育经纪人三级、体育经理人三级。2011 年 6 月参加工作，曾任深圳市盐田体育 中心办公室主任，济宁珠江体育文化发展有限公司市场开发部部门经理、高新 区体育馆项目总经理、总经理助理、常务副总经理，广州珠江体育文化发展股 份有限公司总经理助理、第二党支部书记、第三党支部书记、副总经理，现任 广州珠江体育文化发展股份有限公司常务副总经理，本公司党委委员。 截至目前，赵坤先生未持有公司股票，未受过中国证券监督管理委员会及 其他相关部门的处罚和上海证券交易所惩戒，不存在《中华人民共和国公司法》 等法律法规及其他有关规定不得担任上市公司董事、监事和高级管理人员的情 形。 特此公告。 广州珠江发展集团股份有限公司董事会 2025 年 7 月 3 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 7 月 1 日 ...

证券代码：600684 证券简称：珠江股份 编号：2025-036 广州珠江发展集团股份有限公司 第十一届董事会 2025 年第六次会议决议 公告 根据战略规划实施情况及实际经营情况，以精简高效、有效运作为原则， 同意调整公司组织架构。原 14 个部门调整为 10 个部门，调整后的部门分别为： 综合管理部、财务部、法律合规部、党群工作部、审计部、纪委办公室、资本 运营部/董事会办公室、战略投资部、公共关系部、数字信息部。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 广州珠江发展集团股份有限公司（以下简称"公司"）第十一届董事会 2025 年第六次会议于 2025 年 6 月 26 日以办公软件或电子邮件方式发出会议通 知及材料汇编，会议于 2025 年 7 月 1 日以通讯方式召开。本次会议应出席董事 8 人，实际出席董事 8 人，由公司董事长李超佐先生召集并主持。会议的召集、 召开和表决程序符合有关法律、行政法规、部门规章、规范性文件和《公司章 程》的规定，并形成了如下决议： 一、审议通过《关于聘任副总经理的议案》 表决 ...

Group 1 - The autonomous driving sector is experiencing significant activity, with notable stock price increases [1] - Keda Control has seen its stock rise by over 10% [1] - Other companies such as Rihai Intelligent, Wavelength Optoelectronics, Zhujiang Shares, and Tengjing Technology are also witnessing stock price increases [1]

重要内容提示： 证券代码：600684 证券简称：珠江股份 公告编号：2025-035 广州珠江发展集团股份有限公司 关于廖惠敏辞去公司董事职务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 廖惠敏女士在公司任职期间，恪尽职守、勤勉尽责，为公司的规范运作与持 续发展发挥了积极作用。公司董事会对廖惠敏女士为公司发展所做出的贡献表示 衷心的感谢！ 特此公告。 广州珠江发展集团股份有限公司董事会 2025 年 6 月 25 日 广州珠江发展集团股份有限公司（以下简称"公司"）第十一届董事会于近 日收到公司董事廖惠敏女士提交的书面辞职函。 二、离任对公司的影响 截至本公告披露日，廖惠敏女士持有公司股票 76,700 股，不存在应履行而 未履行完毕的公开承诺，辞职后其将继续遵守相关法律法规有关股票转让的限制 性规定。 根据《公司法》《公司章程》等相关规定，廖惠敏女士辞去董事职务的辞职 函自送达公司董事会之日起生效。廖惠敏女士辞去董事职务后，将继续在公司控 股子公司担任其他职务，其辞任未导致公司董事会成员人数低于法定人数，不会 影 ...

| 姓名 | 离任职务 | 离任时间 | 原定任期 | | 是否继续在 上市公司及 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | 离任原因 | 其控股子公 | （如适 用） | 毕的公开 | | | | | | | 司任职 | | 承诺 | | 郑蓓 | 副总经理 | 2025-06-06 | 2026-07-13 | 工作调动 | 否 | 不适用 | 否 | 证券代码：600684 证券简称：珠江股份 公告编号：2025-034 广州珠江发展集团股份有限公司 关于郑蓓辞去公司副总经理职务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 广州珠江发展集团股份有限公司（以下简称"公司"）第十一届董事会于近 日收到公司副总经理郑蓓女士提交的书面辞职函。 一、提前离任的基本情况 二、离任对公司的影响 截至本公告披露日，郑蓓女士持有公司股票 25,000 股，不存在应履行而未 履行完毕的公开 ...

Core Viewpoint - The company has decided to adjust the total amount of funds to be raised through a specific issuance of A-shares, reducing it from 747.63 million yuan to 737.63 million yuan, with the net proceeds intended for enhancing liquidity and repaying debts [2][4][22]. Group 1: Meeting Resolutions - The company's board of directors held an emergency meeting on May 30, 2025, where they unanimously approved the adjustment of the fundraising scale [1][7]. - The board's decision to adjust the fundraising amount is within the authorization granted by previous shareholder meetings, thus not requiring further approval [3][9]. Group 2: Fundraising Details - The adjusted total fundraising amount (including issuance costs) is now capped at 737.63 million yuan, with the net proceeds to be used entirely for liquidity enhancement and debt repayment [2][8][14]. - The number of shares to be issued has been adjusted to a maximum of 252,613,560 shares due to the reduction in the fundraising amount [2][16][22]. Group 3: Related Party Transactions - The company signed a supplementary agreement with its controlling shareholder, Guangzhou Zhujiang Industrial Group Co., Ltd., regarding the share subscription, which is part of the related party transaction [5][20][27]. - The controlling shareholder holds 31.10% of the company's shares, making this transaction a related party transaction as per regulatory definitions [24][22]. Group 4: Financial Implications - The fundraising is expected to improve the company's capital strength and financial structure, thereby enhancing its competitive position in the market [29][36]. - The issuance is projected to lower the company's debt-to-asset ratio and optimize its financial structure, which is anticipated to benefit shareholders in the long run [29][36].

Core Points - The company has adjusted its plan for the issuance of A-shares to specific investors, reducing the total fundraising amount from 747.63 million yuan to 737.63 million yuan [1][2] - The number of shares to be issued has been revised from a maximum of 256,038,216 shares to 252,613,560 shares, which remains within 30% of the total share capital prior to the issuance [2][3] - The adjustments were approved by the company's board and do not require further shareholder approval as they fall within the board's authorized scope [1] Fundraising Details - The total amount to be raised, including issuance costs, is now capped at 737.63 million yuan, which will be used entirely for replenishing working capital and repaying debts [1][3] - The final number of shares to be issued will be determined based on the approval from the China Securities Regulatory Commission [2][3] Agreement Adjustments - A supplementary agreement was signed with Zhujiang Industrial Group, modifying the original share subscription agreement to reflect the new fundraising amount and share issuance quantity [3]